Novartis

Articles by Novartis

Automation of MS Analytics for Characterization of Biotherapeutics

March 17th 2022

March 17th 2022 at 10am EST | 9am CST | 3pm GMT | 4pm CET • Automating and Streamlining MS-Based Developability Assessment of Biotherapeutics• Automating MS-Based Biotherapeutic Characterization Workflows for Developability

Latest Updated Articles

Trending on BioPharm International

Regulatory Challenges for Global Manufacturing of Vaccines

AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D

EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation

Executive Summary: Charge Detection Mass Spectrometry (CDMS): From Complexity to Clarity – A New Era in Biomolecular Analysis

Q&A: From Lab to Clinic—Leveraging Organ-on-Chip and AI to Improve Therapeutic Development